Advancing the precision management of inflammatory bowel disease in the era of omics approaches and new technology

There is great heterogeneity among inflammatory bowel disease (IBD) patients in terms of pathogenesis, clinical manifestation, response to treatment, and prognosis, which requires the individualized and precision management of patients. Many studies have focused on prediction biomarkers and models f...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Xin-Yu, Tang, Hao, Zhou, Qing-Yang, Zeng, Yan-Lin, Chen, Dan, Xu, Hui, Li, Yue, Tan, Bei, Qian, Jia-Ming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9846940/
https://www.ncbi.nlm.nih.gov/pubmed/36687128
http://dx.doi.org/10.3748/wjg.v29.i2.272

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9846940/
https://www.ncbi.nlm.nih.gov/pubmed/36687128
http://dx.doi.org/10.3748/wjg.v29.i2.272

Ejemplares similares